Quantitative SSTR-PET/CT for predicting response and survival outcomes in patients with pancreatic neuroendocrine tumors receiving CAPTEM
, , , , , , , und
30. Nov. 2023
Über diesen Artikel
Artikel-Kategorie: Research Article
Online veröffentlicht: 30. Nov. 2023
Seitenbereich: 436 - 445
Eingereicht: 05. Juni 2023
Akzeptiert: 25. Sept. 2023
DOI: https://doi.org/10.2478/raon-2023-0055
Schlüsselwörter
© 2023 Maria Ingenerf et al., published by Sciendo
This work is licensed under the Creative Commons Attribution 4.0 International License.
Ingenerf, Maria
Department of Radiology, University Hospital, LMU MunichMunich, Germany
Karim, Homeira
Department of Radiology, University Hospital, LMU MunichMunich, Germany
Auernhammer, Christoph
ENETS Centre of Excellence, Interdisciplinary Center of Neuroendocrine Tumours of the GastroEnteroPancreatic System at the University Hospital of Munich (GEPNET-KUM), University Hospital of MunichMunich, Germany
Department of Internal Medicine, University Hospital, LMU MunichMunich, Germany
Zacherl, Matthias
Department of Nuclear Medicine, University Hospital, LMU MunichMunich, Germany
Wenter, Vera
Department of Nuclear Medicine, University Hospital, LMU MunichMunich, Germany
Winkelmann, Michael
Department of Radiology, University Hospital, LMU MunichMunich, Germany
Ricke, Jens
Department of Radiology, University Hospital, LMU MunichMunich, Germany
ENETS Centre of Excellence, Interdisciplinary Center of Neuroendocrine Tumours of the GastroEnteroPancreatic System at the University Hospital of Munich (GEPNET-KUM), University Hospital of MunichMunich, Germany
Berger, Frank
Department of Radiology, University Hospital, LMU MunichMunich, Germany
Schmid-Tannwald, Christine
Department of Radiology, University Hospital, LMU MunichMunich, Germany
ENETS Centre of Excellence, Interdisciplinary Center of Neuroendocrine Tumours of the GastroEnteroPancreatic System at the University Hospital of Munich (GEPNET-KUM), University Hospital of MunichMunich, Germany